Aims Latest evidence suggests a potential role of angiotensin II in the physiological regulation of erythropoietin (Epo) production. Epo was noticed [AUCEpo: placebo 5709 243 (% of baseline h), furosemide: 5833 255 (% of baseline h); 95% self-confidence period (CI) ?608.4, 856.0; = 0.73]. F reduced GFR (from 103.6 4.0 to 90.6 4.8 ml min?1… Continue reading Aims Latest evidence suggests a potential role of angiotensin II in